Application number | Title of the application | Filing Date | Status |
---|
07/935811 | HLA-RESTRICTED HEPATITIS B VIRUS CTL EPITOPES | Aug 25, 1992 | Abandoned |
Array
(
[id] => 3558275
[patent_doc_number] => 05525338
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-06-11
[patent_title] => 'Detection and therapy of lesions with biotin/avidin conjugates'
[patent_app_type] => 1
[patent_app_number] => 7/933982
[patent_app_country] => US
[patent_app_date] => 1992-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9337
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/525/05525338.pdf
[firstpage_image] =>[orig_patent_app_number] => 933982
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/933982 | Detection and therapy of lesions with biotin/avidin conjugates | Aug 20, 1992 | Issued |
Array
(
[id] => 3114312
[patent_doc_number] => 05380513
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-01-10
[patent_title] => 'Methods for reducing non-target retention of immunoconjugates and metabolites thereof'
[patent_app_type] => 1
[patent_app_number] => 7/933608
[patent_app_country] => US
[patent_app_date] => 1992-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5652
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/380/05380513.pdf
[firstpage_image] =>[orig_patent_app_number] => 933608
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/933608 | Methods for reducing non-target retention of immunoconjugates and metabolites thereof | Aug 20, 1992 | Issued |
Array
(
[id] => 3046825
[patent_doc_number] => 05334702
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-08-02
[patent_title] => 'Compositions which are immunologically crossreactive with antibodies and preparative methods therefor'
[patent_app_type] => 1
[patent_app_number] => 7/933013
[patent_app_country] => US
[patent_app_date] => 1992-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 5915
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/334/05334702.pdf
[firstpage_image] =>[orig_patent_app_number] => 933013
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/933013 | Compositions which are immunologically crossreactive with antibodies and preparative methods therefor | Aug 19, 1992 | Issued |
Array
(
[id] => 3061094
[patent_doc_number] => 05352447
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-10-04
[patent_title] => 'Immunotoxins for treatment of intracranial lesions and as adjunct to chemotherapy'
[patent_app_type] => 1
[patent_app_number] => 7/925417
[patent_app_country] => US
[patent_app_date] => 1992-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 10220
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/352/05352447.pdf
[firstpage_image] =>[orig_patent_app_number] => 925417
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/925417 | Immunotoxins for treatment of intracranial lesions and as adjunct to chemotherapy | Aug 9, 1992 | Issued |
07/910038 | NOVEL VACCINE AND METHOD THEREFOR | Aug 6, 1992 | Abandoned |
Array
(
[id] => 3424515
[patent_doc_number] => 05422281
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-06
[patent_title] => 'Bidentate conjugate and method of use thereof'
[patent_app_type] => 1
[patent_app_number] => 7/923188
[patent_app_country] => US
[patent_app_date] => 1992-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11006
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/422/05422281.pdf
[firstpage_image] =>[orig_patent_app_number] => 923188
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/923188 | Bidentate conjugate and method of use thereof | Jul 30, 1992 | Issued |
Array
(
[id] => 3046408
[patent_doc_number] => 05306492
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-04-26
[patent_title] => 'Oligosaccharide conjugate vaccines'
[patent_app_type] => 1
[patent_app_number] => 7/921678
[patent_app_country] => US
[patent_app_date] => 1992-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 12192
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/306/05306492.pdf
[firstpage_image] =>[orig_patent_app_number] => 921678
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/921678 | Oligosaccharide conjugate vaccines | Jul 29, 1992 | Issued |
07/922307 | APAMIN BINDING PROTEIN/RECEPTOR | Jul 29, 1992 | Abandoned |
07/927541 | IMMUNOGLOBULIN CONJUGATES | Jul 23, 1992 | Abandoned |
07/901919 | CARRIER SYSTEM AND METHOD FOR THE INTRODUCTION OF GENES INTO MAMMALIAN CELLS | Jul 23, 1992 | Abandoned |
07/915004 | CLEAVABLE CONJUGATES FOR THE DELIVERY AND RELEASE OF AGENTS IN NATIVE FORM | Jul 15, 1992 | Abandoned |
07/907409 | IMMUNOTOXIN WITH IN-VIVO T CELL SUPPRESSANT ACTIVITY | Jun 30, 1992 | Abandoned |
Array
(
[id] => 3006319
[patent_doc_number] => 05354691
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1994-10-11
[patent_title] => 'Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions'
[patent_app_type] => 1
[patent_app_number] => 7/893783
[patent_app_country] => US
[patent_app_date] => 1992-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3485
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/354/05354691.pdf
[firstpage_image] =>[orig_patent_app_number] => 893783
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/893783 | Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions | Jun 4, 1992 | Issued |
Array
(
[id] => 3471681
[patent_doc_number] => 05427782
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-06-27
[patent_title] => 'Intranasal immunization against viral infection using viral glycoprotein subunit vaccine'
[patent_app_type] => 1
[patent_app_number] => 7/887130
[patent_app_country] => US
[patent_app_date] => 1992-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 6309
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/427/05427782.pdf
[firstpage_image] =>[orig_patent_app_number] => 887130
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/887130 | Intranasal immunization against viral infection using viral glycoprotein subunit vaccine | May 19, 1992 | Issued |
Array
(
[id] => 2948796
[patent_doc_number] => 05180815
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1993-01-19
[patent_title] => 'Modified protein for carrying hapten'
[patent_app_type] => 1
[patent_app_number] => 7/880292
[patent_app_country] => US
[patent_app_date] => 1992-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 6255
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/180/05180815.pdf
[firstpage_image] =>[orig_patent_app_number] => 880292
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/880292 | Modified protein for carrying hapten | May 4, 1992 | Issued |
07/877613 | MULTIPLE ANTIGEN PEPTIDE SYSTEM HAVING ADJUVANT PROPERTIES, VACCINES PREPARED THEREFROM AND METHODS OF USE THEREOF | Apr 30, 1992 | Abandoned |
07/875788 | BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND ERBB-2 RECEPTOR | Apr 28, 1992 | Abandoned |
Array
(
[id] => 3106794
[patent_doc_number] => 05407834
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-04-18
[patent_title] => 'Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit'
[patent_app_type] => 1
[patent_app_number] => 7/831762
[patent_app_country] => US
[patent_app_date] => 1992-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 32
[patent_no_of_words] => 13715
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/407/05407834.pdf
[firstpage_image] =>[orig_patent_app_number] => 831762
[rel_patent_id] =>[rel_patent_doc_number] =>) 07/831762 | Phencyclidine and phencyclidine metabolites assay, tracers, immunogens, antibodies and reagent kit | Apr 26, 1992 | Issued |
07/869386 | VACCINE ADJUVANT | Apr 15, 1992 | Abandoned |